Effects of Dapagliflozin in Patients with Heart Failure and Deterioration of Kidney Function Below eGFR 25ml/min/1.73m^2

Back

ESC Professional Premium Access

Effects of Dapagliflozin in Patients with Heart Failure and Deterioration of Kidney Function Below eGFR 25ml/min/1.73m^2

Session: Clinical trial updates on heart failure

Topic: Pharmacotherapy

Speaker: Professor S. Solomon (Boston, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

5 more presentations in this session

EMPEROR - Empagliflozin in Patients with Chronic Heart Failure

Speaker: Professor M. Packer (Dallas, US)

Access

Slides

Video

Renal Outcomes in PARAGLIDE-HF and PARAGON-HF

Speaker: Doctor M. Vaduganathan (Boston, US)

Access

Slides

Video

STRONG-HF

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access

Slides

Video

OPT-PACE - Optimising therapy in patients with pacemakers

Speaker: Doctor K. Witte (Leeds, GB)

Access

Slides

Video

The ADVOR trial: update on renal interactions

Speaker: Doctor J. Dauw (Aalst, BE)

Access

Slides

Video

Access the full session

Clinical trial updates on heart failure

Speakers: Professor S. Solomon, Professor M. Packer, Doctor M. Vaduganathan, Professor P. Ponikowski, Doctor K. Witte...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources